Stock Scorecard



Stock Summary for Retractable Technologies Inc (RVP) - $0.77 as of 1/9/2026 8:27:37 PM EST

Total Score

13 out of 30

Safety Score

8 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RVP

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RVP

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RVP

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for RVP

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for RVP (8 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 2
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 1
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for RVP

Safety Syringes Market Analysis 2025 : Market Size, Growth 12/31/2025 10:09:00 AM
Retractable Technologies Declares Dividend on Convertible Preferred Shares 12/31/2025 9:08:00 AM
Maker of retractable syringes pays cash dividends on preferred stock 12/30/2025 9:08:00 PM
RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures 12/6/2025 4:09:00 PM
Trends & Strategies Shaping the $2.22 Billion Smart Syringes Market, 2025-2033 - Government-Led Immunization Initiatives Propel Uptake of Auto-Disable Smart Syringes - ResearchAndMarkets.com 12/6/2025 4:09:00 PM
Trends & Strategies Shaping the $2.22 Billion Smart Syringes Market, 2025-2033 - Government-Led Immunization Initiatives Propel Uptake of Auto-Disable Smart Syringes - ResearchAndMarkets.com 12/4/2025 2:08:00 PM
RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures 11/20/2025 2:08:00 PM
Retractable Technologies (NYSE American: RVP) posts $10.1M Q3 sales; U.S. output 38.3% 11/17/2025 4:50:00 AM
Shaw Thomas J, president and CEO, buys Retractable Technologies (RVP) shares 11/17/2025 4:50:00 AM
Ret retractable (RVP) receives Vizient Innovative Technology designation for EasyPoint 11/17/2025 4:50:00 AM

Financial Details for RVP

Company Overview

Ticker RVP
Company Name Retractable Technologies Inc
Country N/A
Description Retractable Technologies, Inc. (RVP) is a prominent player in the medical device industry, specializing in the design and manufacture of innovative safety syringes aimed at reducing needle-stick injuries and enhancing patient safety. Headquartered in Little Elm, Texas, the company serves a broad client base domestically and internationally, positioning itself as an essential partner in healthcare. With a steadfast commitment to innovation and quality, Retractable Technologies is well-positioned for future growth as it seeks to expand its product portfolio and fortify its global market presence.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 6/30/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 0.77
Price 4 Years Ago 1.64
Last Day Price Updated 1/9/2026 8:27:37 PM EST
Last Day Volume 20,360
Average Daily Volume 38,913
52-Week High 1.14
52-Week Low 0.62
Last Price to 52 Week Low 24.19%

Valuation Measures

Trailing PE N/A
Industry PE 55.80
Sector PE 55.07
5-Year Average PE 1.83
Free Cash Flow Ratio 6.42
Industry Free Cash Flow Ratio 42.80
Sector Free Cash Flow Ratio 32.93
Current Ratio Most Recent Quarter 6.66
Total Cash Per Share 0.12
Book Value Per Share Most Recent Quarter 2.55
Price to Book Ratio 0.30
Industry Price to Book Ratio 3.83
Sector Price to Book Ratio 37.07
Price to Sales Ratio Twelve Trailing Months 0.61
Industry Price to Sales Ratio Twelve Trailing Months 85.23
Sector Price to Sales Ratio Twelve Trailing Months 12.84
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 29,937,200
Market Capitalization 23,051,644
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.83%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -66.70%
Annual Earnings Growth -69.54%
Reported EPS 12 Trailing Months -0.30
Reported EPS Past Year -0.35
Reported EPS Prior Year -0.40
Net Income Twelve Trailing Months -6,446,418
Net Income Past Year -11,886,524
Net Income Prior Year -7,011,036
Quarterly Revenue Growth YOY 73.20%
5-Year Revenue Growth -4.59%
Operating Margin Twelve Trailing Months -49.10%

Balance Sheet

Total Cash Most Recent Quarter 3,444,538
Total Cash Past Year 4,235,388
Total Cash Prior Year 12,667,550
Net Cash Position Most Recent Quarter 2,820,933
Net Cash Position Past Year 3,335,346
Long Term Debt Past Year 900,042
Long Term Debt Prior Year 1,233,519
Total Debt Most Recent Quarter 623,605
Equity to Debt Ratio Past Year 0.99
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 87,170,691
Total Stockholder Equity Prior Year 99,287,659
Total Stockholder Equity Most Recent Quarter 76,780,718

Free Cash Flow

Free Cash Flow Twelve Trailing Months -14,008,560
Free Cash Flow Per Share Twelve Trailing Months -0.47
Free Cash Flow Past Year -12,996,980
Free Cash Flow Prior Year 1,913,870

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.73
20-Day Bollinger Middle Band 0.84
20-Day Bollinger Upper Band 0.95
Beta 1.14
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 1/8/2026 7:18:25 AM EST